Bleeding and Clotting Disorders Institute Peoria, Illinois
1 clinical trials · Sponsor
◉ Watch Bleeding and Clotting Disorders Institute Peoria, Illinois
| Record | Firm | Date |
|---|---|---|
| Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A (NCT05500807) | Bleeding and Clotting Disorders Institute Peoria, Illinois | 2022-11-01 |
Track Bleeding and Clotting Disorders Institute Peoria, Illinois automatically
Every clearance here is in the API, with alerts when new ones post.